BSPD point of contact:
Dr Ruth Murphy,
The BSPD Executive Committee:
Dr Fiona Browne is a Consultant Dermatologist at Crumlin Children’s Hospital and Temple St Children’s Hospital, Dublin. She qualified in Medicine from Queen’s University Belfast in 2001 and trained in Dermatology in Leeds. She undertook a post CCT fellowship in Paediatric Dermatology at Birmingham Children’s Hospital where she then worked as Consultant from 2011 to 2015. She has a specialist interest in Epidermolysis Bullosa and Genodermatoses.
Reader and Consultant in Dermatology and Research & Development Lead at St John’s Institute of Dermatology, King’s College London and Guy’s & St Thomas’ NHS Foundation Trust, where he directs the Population-Based Dermatology Research Unit. He is also Speciality Lead for the South London National Institute for Health Research (NIHR) Comprehensive Research Network (CRN).
Paediatric Dermatologist at Great Ormond Street Hospital and Trustee of the charity Changing Faces.
Dr Helen Goodyear is a Consultant Paediatrician with a special interest in Paediatric Dermatology. Additionally, she has a strong interest in medical education. She is the Associate Postgraduate Dean in the West Midlands for LTFT training, careers and professional support and is Head of the School of Paediatrics.
Consultant Dermatologist in NHS Borders, being Clincal lead for Paediatric Dermatology Service. Other specialist interest in Dermatological Surgery.
Consultant Dermatologist and Senior Clinical Lecturer in charge of Paediatric Dermatology services in Oxford. Areas of interests: Adolescent Dermatology, Atopic Eczema, Acne, Psoriasis, Patient experiences of skin disease and Undergraduate education. Establishing a web resource (SKINS) for young adults with skin disease (healthtalk.org.uk).
Consultant Dermatologist at St John’s Institute of Dermatology and Great Ormond Street since 2003. Expert in epidermolysis bullosa and other genodermatoses, as well as paediatric dermatology, lead for Paediatric and Genetic Dermatology at St John’s. Also active research into genodermatoses and paediatric dermatology, including novel cellular therapies and ex vivo gene therapy.